Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler.

Connor BA, Patron DJ.

J Occup Environ Med. 2008 Aug;50(8):945-50. doi: 10.1097/JOM.0b013e3181808081.

PMID:
18695453
2.

Risk and burden associated with the acquisition of viral hepatitis A and B in the corporate traveler.

Bunn WB 3rd.

J Occup Environ Med. 2008 Aug;50(8):935-44. doi: 10.1097/JOM.0b013e3181808096.

PMID:
18695452
3.

Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers.

Nothdurft HD, Zuckerman J, Stoffel M, Dieussaert I, Van Damme P.

J Travel Med. 2004 Jul-Aug;11(4):260-1. Review. No abstract available.

4.

The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.

Keystone JS, Hershey JH.

Int J Infect Dis. 2008 Jan;12(1):3-11. Epub 2007 Jul 20. Review.

5.

Hepatitis B risks and immunization coverage among American travelers.

Connor BA, Jacobs RJ, Meyerhoff AS.

J Travel Med. 2006 Sep-Oct;13(5):273-80.

6.

Vaccination of travelers against hepatitis A and B.

Löscher T, Keystone JS, Steffen R.

J Travel Med. 1999 Jun;6(2):107-14. Review.

7.

A review of combined hepatitis A and hepatitis B vaccination for travelers.

Spira AM.

Clin Ther. 2003 Sep;25(9):2337-51. Review.

PMID:
14604737
8.

Pretravel advice and hepatitis A immunization among Australian travelers.

Zwar N, Streeton CL; Travel Health Advisory Group.

J Travel Med. 2007 Jan-Feb;14(1):31-6.

9.

Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.

Nothdurft HD, Dietrich M, Zuckerman JN, Knobloch J, Kern P, Sänger R.

BioDrugs. 2003;17 Suppl 1:15-8. No abstract available.

PMID:
12785873
10.

Travel-related hepatitis B: risk factors and prevention using an accelerated vaccination schedule.

Keystone JS.

Am J Med. 2005 Oct;118 Suppl 10A:63S-68S. Review.

PMID:
16271544
11.
12.

The place of accelerated schedules for hepatitis A and B vaccinations.

Zuckerman J.

Drugs. 2003;63(17):1779-84. Review.

PMID:
12921484
13.

Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.

Beran J.

Expert Rev Vaccines. 2007 Dec;6(6):891-902. doi: 10.1586/14760584.6.6.891. Review.

PMID:
18377352
14.
15.

Overview of selected infectious disease risks for the corporate traveler.

Hudson TW, Fortuna J.

J Occup Environ Med. 2008 Aug;50(8):924-34. doi: 10.1097/JOM.0b013e318180804f. Review.

PMID:
18695451
16.

The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.

Oldfield EC 3rd, Keeffe EB.

Rev Gastroenterol Disord. 2007 Winter;7(1):1-21. Review.

PMID:
17392626
17.

Twinrix vaccination schedules among injecting drug users.

Brim N, Zaller N, Taylor LE, Feller E.

Expert Opin Biol Ther. 2007 Mar;7(3):379-89.

PMID:
17309329
18.

Travel health knowledge, attitudes and practices among United States travelers.

Hamer DH, Connor BA.

J Travel Med. 2004 Jan-Feb;11(1):23-6.

19.

Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.

Köksal Y, Varan A, Aydin GB, Sari N, Yazici N, Yalcin B, Kutluk T, Akyuz C, Büyükpamukçu M.

Pediatr Hematol Oncol. 2007 Dec;24(8):587-94.

PMID:
18092249
20.

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.

Van Damme P, Van Herck K.

Expert Rev Vaccines. 2004 Jun;3(3):249-67. Review.

PMID:
15176942
Items per page

Supplemental Content

Write to the Help Desk